Palo Alto Investors

Latest statistics and disclosures from Palo Alto Investors's latest quarterly 13F-HR filing:

Tip: Access up to 7 years of quarterly data

Positions held by Palo Alto Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Palo Alto Investors

Companies in the Palo Alto Investors portfolio as of the December 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Staar Surgical Com Par $0.01 (STAA) 11.8 $226M +2% 2.8M 79.22
Insmed Com Par $.01 (INSM) 10.7 $203M 6.1M 33.29
BioMarin Pharmaceutical (BMRN) 9.9 $189M +24% 2.2M 87.69
Amicus Therapeutics (FOLD) 9.5 $182M 7.9M 23.09
Abiomed (ABMD) 9.5 $181M +10% 557k 324.20
ACADIA Pharmaceuticals (ACAD) 6.4 $123M +25% 2.3M 53.46
United Therapeutics Corporation (UTHR) 6.2 $119M 785k 151.79
Karyopharm Therapeutics (KPTI) 4.3 $82M +3% 5.3M 15.48
Alexion Pharmaceuticals (ALXN) 4.1 $79M +10% 503k 156.24
Revance Therapeutics (RVNC) 4.0 $76M +34% 2.7M 28.34
Epizyme (EPZM) 3.8 $73M +5% 6.7M 10.86
Biogen Idec (BIIB) 3.0 $57M NEW 234k 244.86
Vanda Pharmaceuticals (VNDA) 2.9 $56M 4.2M 13.14
Sage Therapeutics (SAGE) 2.7 $51M 590k 86.51

Setup an alert

Palo Alto Investors will file the next quarterly 13-HR in about 1 months. Would you like to be notified?

eHealth (EHTH) 2.2 $41M +109% 587k 70.61
Align Technology (ALGN) 1.9 $36M 68k 534.38
Clovis Oncology (CLVS) 1.1 $22M 4.5M 4.80
Prothena Corp SHS (PRTA) 1.1 $20M +27% 1.7M 12.01
Gossamer Bio (GOSS) 0.9 $17M +61% 1.7M 9.67
Puma Biotechnology (PBYI) 0.7 $14M 1.4M 10.26
Anaptysbio Inc Common (ANAB) 0.5 $8.9M +12% 416k 21.50
Dicerna Pharmaceuticals (DRNA) 0.4 $7.3M 332k 22.03
Kaleido Biosciences Ord (KLDO) 0.4 $7.2M 786k 9.10
Syndax Pharmaceuticals (SNDX) 0.3 $5.9M +33% 264k 22.24
Travere Therapeutics (TVTX) 0.2 $4.3M NEW 158k 27.26
Zogenix Com New (ZGNX) 0.2 $4.3M +31% 215k 19.99
Athenex (ATNX) 0.2 $3.5M +23% 318k 11.06
Rigel Pharmaceuticals Com New (RIGL) 0.2 $3.5M -15% 998k 3.50
Magenta Therapeutics (MGTA) 0.2 $3.3M +24% 427k 7.84
Alkermes SHS (ALKS) 0.2 $3.0M NEW 151k 19.95
Kezar Life Sciences (KZR) 0.2 $2.9M +12% 548k 5.22
Cytokinetics Com New (CYTK) 0.1 $2.6M 124k 20.78
Tactile Systems Technology, In (TCMD) 0.1 $1.2M NEW 27k 44.94
Aldeyra Therapeutics (ALDX) 0.1 $1.1M +36% 161k 6.86
Alimera Sciences Com New (ALIM) 0.0 $848k 201k 4.22
Aprea Therapeutics (APRE) 0.0 $634k +7% 129k 4.92
Urogen Pharma (URGN) 0.0 $441k 25k 18.00
Marinus Pharmaceuticals 0.0 $382k 31k 12.19
Idera Pharmaceuticals Com Par (IDRA) 0.0 $283k 77k 3.67
Sunesis Pharmaceuticals Inc Ne 0.0 $231k 116k 1.99
Minerva Neurosciences (NERV) 0.0 $85k 36k 2.34

Past Filings by Palo Alto Investors

SEC 13F filings are viewable for Palo Alto Investors going back to 2010

View all past filings